Rapamycin and Acarbose Extend Lifespan by 30%
D
Dr. Elana Miller in 'Health Talks Episode 1' (GetHealthSpan Channel)
Anti-AgingMedicalTesting
Story of claim
In mouse models, rapamycin and acarbose increase lifespan by 30% by targeting aging pathways, suggesting potential anti-aging benefits.
- Goal: Extend lifespan by targeting aging pathways.
- Proof: Combination targets distinct but complementary aging pathways, promoting lifespan extension in mice.
- Nuances:
- Rapamycin and acarbose complement each other well.
- Promote health span and lifespan by targeting distinct aging pathways.
- Impact on Life: May offer significant anti-aging benefits, potentially extending health span and lifespan.
Investments
- Price: Research-related costs, varies widely
- Time: Ongoing research; clinical application not yet established
- Effort: Requires scientific research and development
Risks
Potential side effects of rapamycin; not yet proven in humans.
Alternatives
- Dietary interventions targeting aging
- Other longevity-promoting compounds like metformin
Get Started 🚀
- Follow developments in anti-aging research
- Consider dietary and lifestyle changes supporting longevity
- Stay informed about clinical trials involving rapamycin and acarbose
- Discuss potential participation in research studies with a healthcare provider
Brogevity AI can make mistakes. Check important info.